vs
Side-by-side financial comparison of Mind Medicine (MindMed) Inc. (DFTX) and Laser Photonics Corp (LASE). Click either name above to swap in a different company.
Laser Photonics Corp is the larger business by last-quarter revenue ($919.3K vs $906.0K, roughly 1.0× Mind Medicine (MindMed) Inc.). Laser Photonics Corp runs the higher net margin — -506.4% vs -2634.0%, a 2127.6% gap on every dollar of revenue. On growth, Laser Photonics Corp posted the faster year-over-year revenue change (28.3% vs -16.1%).
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
DFTX vs LASE — Head-to-Head
Income Statement — Q4 FY2023 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $906.0K | $919.3K |
| Net Profit | $-23.9M | $-4.7M |
| Gross Margin | — | -20.1% |
| Operating Margin | -2450.8% | -350.0% |
| Net Margin | -2634.0% | -506.4% |
| Revenue YoY | -16.1% | 28.3% |
| Net Profit YoY | -386.7% | -186.5% |
| EPS (diluted) | $-0.58 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $919.3K | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | — | $716.7K | ||
| Q2 24 | — | $623.4K | ||
| Q1 24 | — | $743.0K | ||
| Q4 23 | $906.0K | $994.6K |
| Q3 25 | — | $-4.7M | ||
| Q2 25 | — | $-1.8M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $586.4K | ||
| Q3 24 | — | $-1.6M | ||
| Q2 24 | — | $-934.3K | ||
| Q1 24 | — | $-545.7K | ||
| Q4 23 | $-23.9M | $-486.6K |
| Q3 25 | — | -20.1% | ||
| Q2 25 | — | 53.5% | ||
| Q1 25 | — | 49.8% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | 85.0% | ||
| Q2 24 | — | 50.6% | ||
| Q1 24 | — | 51.9% | ||
| Q4 23 | — | 84.5% |
| Q3 25 | — | -350.0% | ||
| Q2 25 | — | -37.0% | ||
| Q1 25 | — | -68.7% | ||
| Q4 24 | — | -255.1% | ||
| Q3 24 | — | -238.0% | ||
| Q2 24 | — | -149.4% | ||
| Q1 24 | — | -73.8% | ||
| Q4 23 | -2450.8% | -88.4% |
| Q3 25 | — | -506.4% | ||
| Q2 25 | — | -68.3% | ||
| Q1 25 | — | -73.4% | ||
| Q4 24 | — | 45.7% | ||
| Q3 24 | — | -226.8% | ||
| Q2 24 | — | -149.9% | ||
| Q1 24 | — | -73.4% | ||
| Q4 23 | -2634.0% | -48.9% |
| Q3 25 | — | $-0.27 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | — | $-0.13 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.06 | ||
| Q4 23 | $-0.58 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.7M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $78.1M | $4.1M |
| Total Assets | $124.5M | $17.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $78.5K | ||
| Q1 25 | — | $179.1K | ||
| Q4 24 | — | $533.9K | ||
| Q3 24 | — | $2.1M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $5.2M | ||
| Q4 23 | $99.7M | $6.2M |
| Q3 25 | — | $4.1M | ||
| Q2 25 | — | $4.3M | ||
| Q1 25 | — | $6.8M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | — | $9.7M | ||
| Q2 24 | — | $10.3M | ||
| Q1 24 | — | $12.4M | ||
| Q4 23 | $78.1M | $13.9M |
| Q3 25 | — | $17.5M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $16.0M | ||
| Q4 24 | — | $17.2M | ||
| Q3 24 | — | $10.6M | ||
| Q2 24 | — | $11.1M | ||
| Q1 24 | — | $13.6M | ||
| Q4 23 | $124.5M | $15.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-20.6M | $763.1K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $763.1K | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $-6.5M | ||
| Q3 24 | — | $632.7K | ||
| Q2 24 | — | $-2.4M | ||
| Q1 24 | — | $-866.3K | ||
| Q4 23 | $-20.6M | $-2.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $589.6K | ||
| Q2 24 | — | $-2.4M | ||
| Q1 24 | — | $-1.0M | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 82.3% | ||
| Q2 24 | — | -388.0% | ||
| Q1 24 | — | -136.9% | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 20.3% | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -11.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
